☆ 4.7 Article

Combination Therapy to Kill Mycobacterium tuberculosis in Its Nonreplicating Persister Phenotype

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Infectious Diseases

Pharmacokinetics of bedaquiline in cerebrospinal fluid (CSF) in patients with pulmonary tuberculosis (TB)

Caryn M. Upton et al.

Summary: This study investigated the pharmacokinetics of bedaquiline and its metabolite M2 in the cerebrospinal fluid of patients with pulmonary TB. The findings suggest that both bedaquiline and M2 can freely penetrate into the CSF of patients with pulmonary TB, with concentrations similar to the estimated unbound fractions in plasma. Clinical studies are urgently needed to determine the potential contribution of bedaquiline in the treatment of CNS TB.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2022)

添加到收藏夹

Article Microbiology

The Funnel: a Screening Technique for Identifying Optimal Two-Drug Combination Chemotherapy Regimens

G. L. Drusano et al.

Summary: The Mycobacterium tuberculosis drug discovery effort has produced numerous new drugs, but the challenge of identifying optimal combination regimens poses a new obstacle. Through a screening process, the combination of pretomanid plus moxifloxacin has emerged as a promising frontrunner for achieving good bacterial burden decline. This screening method may lead to the identification of optimal combinations for further evaluation in different infection models.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

An Algorithm for Nonparametric Estimation of a Multivariate Mixing Distribution with Applications to Population Pharmacokinetics

Walter M. Yamada et al.

Summary: Population pharmacokinetic modeling is essential for drug development and optimal dosing. Our nonparametric maximum likelihood method allows for estimating multivariate mixing distributions without assumptions about shape. This approach is discrete and applicable to high-dimensional mixture models.

PHARMACEUTICS (2021)

添加到收藏夹

Article Microbiology

Building Optimal Three-Drug Combination Chemotherapy Regimens To Eradicate Mycobacterium tuberculosis in Its Slow-Growth Acid Phase

Sarah Kim et al.

Summary: The study utilized a model-informed strategy to accelerate discovery of drug combinations against Mycobacterium tuberculosis in acid-phase metabolic state. The combination of pretomanid and moxifloxacin effectively eradicated M. tuberculosis and prevented emergence of less susceptible isolates in the acid growth phase. Adding bedaquiline as a third drug shortened the time to total and less susceptible bacterial suppression significantly faster than the 2-drug regimen.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

添加到收藏夹

Article Microbiology

Building Optimal Three-Drug Combination Chemotherapy Regimens

G. L. Drusano et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)

添加到收藏夹

Article Microbiology

Contribution of Pretomanid to Novel Regimens Containing Bedaquiline with either Linezolid or Moxifloxacin and Pyrazinamide in Murine Models of Tuberculosis

Jian Xu et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)

添加到收藏夹

Article Microbiology

Effect of Moxifloxacin plus Pretomanid against Mycobacterium tuberculosis in Log Phase, Acid Phase, and Nonreplicating-Persister Phase in an In Vitro Assay

Carolina de Miranda Silva et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)

添加到收藏夹

Article Critical Care Medicine

Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial

Conor D. Tweed et al.

LANCET RESPIRATORY MEDICINE (2019)

添加到收藏夹

Article Microbiology

Linezolid Kills Acid-Phase and Nonreplicative-Persister-Phase Mycobacterium tuberculosis in a Hollow-Fiber Infection Model

G. L. Drusano et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)

添加到收藏夹

Article Microbiology

Effect of Linezolid plus Bedaquiline against Mycobacterium tuberculosis in Log Phase, Acid Phase, and Nonreplicating-Persister Phase in an In Vitro Assay

Carolina de Miranda Silva et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)

添加到收藏夹

Review Microbiology

Metabolic principles of persistence and pathogenicity in Mycobacterium tuberculosis

Sabine Ehrt et al.

NATURE REVIEWS MICROBIOLOGY (2018)

添加到收藏夹

Article Multidisciplinary Sciences

Genetic and metabolic regulation of Mycobacterium tuberculosis acid growth arrest

Jacob J. Baker et al.

SCIENTIFIC REPORTS (2018)

添加到收藏夹

Article Microbiology

Bactericidal and Sterilizing Activity of a Novel Regimen with Bedaquiline, Pretomanid, Moxifloxacin, and Pyrazinamide in a Murine Model of Tuberculosis

Si-Yang Li et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)

添加到收藏夹

Article Chemistry, Medicinal

Synthesis and evaluation of pretomanid (PA-824) oxazolidinone hybrids

Rakesh et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)

添加到收藏夹

Article Microbiology

Preclinical Evaluations To Identify Optimal Linezolid Regimens for Tuberculosis Therapy

Ashley N. Brown et al.

MBIO (2015)

添加到收藏夹

Article Microbiology

Population Pharmacokinetics of Bedaquiline (TMC207), a Novel Antituberculosis Drug

Sarah C. McLeay et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)

添加到收藏夹

Article Biochemistry & Molecular Biology

Slow growth of Mycobacterium tuberculosis at acidic pH is regulated by phoPR and host-associated carbon sources

Jacob J. Baker et al.

MOLECULAR MICROBIOLOGY (2014)

添加到收藏夹

Article Multidisciplinary Sciences

Analysis of Combination Drug Therapy to Develop Regimens with Shortened Duration of Treatment for Tuberculosis

George L. Drusano et al.

PLOS ONE (2014)

添加到收藏夹

Article Medical Laboratory Technology

Accurate Detection of Outliers and Subpopulations With Pmetrics, a Nonparametric and Parametric Pharmacometric Modeling and Simulation Package for R

Michael N. Neely et al.

THERAPEUTIC DRUG MONITORING (2012)

添加到收藏夹

Article Biochemistry & Molecular Biology

aprABC: a Mycobacterium tuberculosis complex-specific locus that modulates pH-driven adaptation to the macrophage phagosome

Robert B. Abramovitch et al.

MOLECULAR MICROBIOLOGY (2011)

添加到收藏夹

Article Microbiology

Simple Model for Testing Drugs against Nonreplicating Mycobacterium tuberculosis

Claudia Sala et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)

添加到收藏夹

Article Microbiology

Safety, Tolerability, and Pharmacokinetics of PA-824 in Healthy Subjects

Ann M. Ginsberg et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)

添加到收藏夹

Review Microbiology

Acid Resistance in Mycobacterium tuberculosis

Omar H. Vandal et al.

JOURNAL OF BACTERIOLOGY (2009)

添加到收藏夹

Article Biochemistry & Molecular Biology

A replication clock for Mycobacterium tuberculosis

Wendy P. Gill et al.

NATURE MEDICINE (2009)

添加到收藏夹

Article Biochemistry & Molecular Biology

A membrane protein preserves intrabacterial pH in intraphagosomal Mycobacterium tuberculosis

Omar H. Vandal et al.

NATURE MEDICINE (2008)

添加到收藏夹

Article Immunology

Growth of Mycobacterium tuberculosis in a defined medium is very restricted by acid pH and Mg2+ levels

DL Piddington et al.

INFECTION AND IMMUNITY (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.